trimethoprim has been researched along with Lymphoma of Mucosa-Associated Lymphoid Tissue in 2 studies
Trimethoprim: A pyrimidine inhibitor of dihydrofolate reductase, it is an antibacterial related to PYRIMETHAMINE. It is potentiated by SULFONAMIDES and the TRIMETHOPRIM, SULFAMETHOXAZOLE DRUG COMBINATION is the form most often used. It is sometimes used alone as an antimalarial. TRIMETHOPRIM RESISTANCE has been reported.
trimethoprim : An aminopyrimidine antibiotic whose structure consists of pyrimidine 2,4-diamine and 1,2,3-trimethoxybenzene moieties linked by a methylene bridge.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Sankaranarayanan, V | 1 |
Zeidalski, TM | 1 |
Chitkara, RK | 1 |
Oscier, D | 1 |
Bramble, J | 1 |
Hodges, E | 1 |
Wright, D | 1 |
2 other studies available for trimethoprim and Lymphoma of Mucosa-Associated Lymphoid Tissue
Article | Year |
---|---|
A 55-year-old smoker with a persistent right lower lobe infiltrate.
Topics: Biopsy, Needle; Bronchoscopy; Diagnosis, Differential; Follow-Up Studies; Gram-Negative Bacterial In | 2005 |
Regression of mucosa-associated lymphoid tissue lymphoma of the bladder after antibiotic therapy.
Topics: Aged; Anti-Bacterial Agents; Cephradine; Drug Therapy, Combination; Female; Humans; Lymphoma, B-Cell | 2002 |